Crafting Custom Care in CLL: Guidance on Upfront and Sequential Treatment Decisions With Targeted and Immune-based Platforms
This program is supported by AstraZeneca, BeiGene, Janssen and Lilly
11:00 a.m. - 2:00 p.m. Pacific time
Marriott Marquis San Diego Marina
San Diego Ballroom AB
On Demand program will be available here December 30, 2024.
Access Program Here
This CME/MOC/AAPA/IPCE activity is provided by PVI, PeerView Institute for Medical Education and developed with our educational partner, CLL Society.
This activity is supported by independent educational grants from AstraZeneca, BeiGene, Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, and Lilly.
In collaboration with CLL Society, PeerView’s unique Clinical Consults event will provide useful information and practical instruction in an engaging, interactive manner designed to explore the rapid transformation of modern CLL therapy. Expert conversations on treatment choices will be paired with practically-oriented case discussions to provide learners with guidance on addressing common clinical challenges arising from the upfront and sequential management of CLL to strategies for integrating emerging, innovative modalities into care. Throughout, the experts will cover:
- Evidence supporting the personalized selection of continuous SOC BTKi or finite 1L regimens;
- The ongoing experience with BTKi-BCL2i combinations;
- Sequential therapy with ncBTKi options and CAR-T immunotherapy in R/R disease;
- Newer modalities such as emerging ncBTKi, next-gen BCL2i, BTK degraders, dual c/ncBTKi, and bispecific antibodies in challenging pre-treated and double-exposed populations.
Don’t miss this opportunity to upgrade your skills in customizing CLL care!
Chair:
Prof. John G. Gribben, MD, DSc
Barts Cancer Institute, Barts and The London School of Medicine, Queen Mary, University of London
London, United Kingdom
Speakers:
Matthew S. Davids, MD, MMSc
Dana-Farber Cancer Institute, Harvard Medical School
Boston, MA
Nicole Lamanna, MD
Herbert Irving Comprehensive Cancer Center, New York-Presbyterian/Columbia University Medical Center
New York, NY
Meghan C. Thompson, MD
Memorial Sloan Kettering Cancer Center
New York, NY
Lauren Wilkes
, PVI, PeerView Institute for Medical Education
Email: lauren.wilkes@peerview.com